Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7U5P

CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2A LIGAND BINDING DOMAIN IN COMPLEX WITH ACTIVIN-A

7U5P の概要
エントリーDOI10.2210/pdb7u5p/pdb
分子名称Activin receptor type-2A, Inhibin beta A chain, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
機能のキーワードcell signaling, receptor-ligand complex, growth factor, receptor interaction, activin a, actriia, signaling protein
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数8
化学式量合計108955.52
構造登録者
Chu, K.Y.,Malik, A.,Thamilselvan, V.,Martinez-Hackert, E. (登録日: 2022-03-02, 公開日: 2022-06-22, 最終更新日: 2024-11-06)
主引用文献Chu, K.Y.,Malik, A.,Thamilselvan, V.,Martinez-Hackert, E.
Type II BMP and activin receptors BMPR2 and ACVR2A share a conserved mode of growth factor recognition.
J.Biol.Chem., 298:102076-102076, 2022
Cited by
PubMed Abstract: BMPR2 is a type II Transforming Growth Factor (TGF)-β family receptor that is fundamentally associated with pulmonary arterial hypertension (PAH) in humans. BMPR2 shares functional similarities with the type II activin receptors ACVR2A and ACVR2B, as it interacts with an overlapping group of TGF-β family growth factors (GFs). However, how BMPR2 recognizes GFs remains poorly understood. Here, we solved crystal structures of BMPR2 in complex with the GF activin B and of ACVR2A in complex with the related GF activin A. We show that both BMPR2 and ACVR2A bind GFs with nearly identical geometry using a conserved hydrophobic hot spot, while differences in contacting residues are predominantly found in loop areas. Upon further exploration of the GF-binding spectrum of the two receptors, we found that although many GFs bind both receptors, the high-affinity BMPR2 GFs comprise BMP15, BMP10, and Nodal, whereas those of ACVR2A are activin A, activin B, and GDF11. Lastly, we evaluated GF-binding domain BMPR2 variants found in human PAH patients. We demonstrate that mutations within the GF-binding interface resulted in loss of GF binding, while mutations in loop areas allowed BMPR2 to retain the ability to bind cognate GFs with high affinity. In conclusion, the in vitro activities of BMPR2 variants and the crystal structures reported here indicate biochemically relevant complexes that explain how some GF-binding domain variants can lead to PAH.
PubMed: 35643319
DOI: 10.1016/j.jbc.2022.102076
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.14 Å)
構造検証レポート
Validation report summary of 7u5p
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon